0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc DRC's Revenue Forecast CAGR (3y):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Revenue Forecast CAGR (3y) in the growth category include:
Three year compound annual growth rate in forecasted revenue.
The chart above depicts the distribution of revenue forecast cagr (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,980 companies were considered in this analysis, and 1,946 had meaningful values. The average revenue forecast cagr (3y) of companies in the sector is 32.3% with a standard deviation of 84.5%.
GSK plc DRC's Revenue Forecast CAGR (3y) of 4.4% ranks in the 36.3% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,986 |
| Included Constituents | 1,946 |
| Min | -100.0% |
| Max | 663.9% |
| Median | 8.2% |
| Mean | 32.3% |
| Standard Deviation | 84.5% |
You can find companies with similar revenue forecast cagr (3y) using this stock screener.